Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • April 2018
  • Case
  • HBS Case Collection

The Bayer—Monsanto Merger: GMOs and 'Science for a Better Life'

By: Martha J. Crawford and James Barnett
  • Format:Print
  • | Language:English
  • | Pages:32
ShareBar

Abstract

This case allows students to explore the economic, ethical and legal challenges faced by agri-business companies, after several decades of promoting and selling Genetically Modified (GM) crops. Starting in the 1980s, the widespread introduction of GM crops was justified as a way to reduce pesticide use and increase yield, benefiting both farmers and consumers. These benefits had only partially materialized. As the agribusiness market entered yet another wave of consolidation in 2016, Bayer’s $66 billion cash bid for Monsanto was stalled by a long and arduous anti-trust review by European regulators. Public protests of the proposed merger were persistent and highly visible, and mounting evidence linked two of Bayer and Monsanto’s key products — neonicotinoid (“neonic”) pesticides and GM seeds — to massive die-offs of bees and other pollinators. In Europe, this evidence had led to bans on GM crops and neonic pesticides in most member countries. Even in the U.S., public demands for GMO-labelling on foods, resisted by agribusiness through lobbying for decades, had finally given way to national legislation, set to take effect in mid-2018. Werner Baumann, CEO of Bayer, pondered what was the best way forward for Bayer, with or without Monsanto.

Keywords

Merger; Acquisition; GMO; Genetically Modified Crops; Neonics; Pesticides; Crop Seeds; EU; Mergers and Acquisitions; Agribusiness; Genetics; Natural Environment; Corporate Social Responsibility and Impact; Governing Rules, Regulations, and Reforms; Consolidation; Agriculture and Agribusiness Industry; Europe; United States

Citation

Crawford, Martha J., and James Barnett. "The Bayer—Monsanto Merger: GMOs and 'Science for a Better Life'." Harvard Business School Case 318-075, April 2018.
  • Educators

More from the Authors

    • October 2022
    • Faculty Research

    Cost Plus Drugs

    By: Alexander MacKay and James Barnett
    • September 2022
    • Faculty Research

    EnergyNow: Powering a New Market

    By: Alexander MacKay and James Barnett
    • September 2022 (Revised December 2022)
    • Faculty Research

    QED Invests in Africa

    By: Álvaro Rodríguez Arregui and James Barnett
More from the Authors
  • Cost Plus Drugs By: Alexander MacKay and James Barnett
  • EnergyNow: Powering a New Market By: Alexander MacKay and James Barnett
  • QED Invests in Africa By: Álvaro Rodríguez Arregui and James Barnett
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College